GLP-1 Receptor Agonists Post-Bariatric Surgery (GRABS) Feasibility Trial

GLP-1 Receptor Agonists Post-Bariatric Surgery (GRABS) Feasibility Trial
Conditions: Severe Obesity

Interventions: Drug: Tirzepatide

Sponsors: Vanderbilt University Medical Center

Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

December 9, 2023Comments OffClinicalTrials.gov | Gastroenterology Clinical Trials | Gastroenterology Studies | US National Library of Medicine
Comments